Correlation Between Platelets Count, Platelet Index and D-Dimer in Covid-19 Patients

Nelly Tolla, Rachmawaty Rachmawaty, Andi Salsa Anggeraini, Darmmawaty R, Faidah Nur

Abstract


Hypercoagulation in the alveoli of the lungs is one of the causes of death in SARS-CoV2 virus infection. Hypercoagulation is defined by an elevation in D-Dimer, which typically rises on the fifth day of therapy. This parameter is not available in all hospitals and is still relatively expensive in preventing premature death. Platelets count and indices are suggested to describe the thromboinflammatory condition in COVID-19 patients. This research is an observational analytic study with a cross-sectional study design in 59 COVID-19 patients treated at Hassanuddin University Hospital. The patients who are declared COVID-19 based on the results of radiological examinations and PCR swabs underwent routine blood tests and D-Dimer before undergoing therapy. Data were analyzed using the Spearmen test in SPSS version 26 to reveal the correlation between platelet count, platelet indices, and D Dimer in COVID-19 patients with severe and non-severe conditions.  Platelet count, platelet indices, especially MPV, and D-Dimer values were found to correlate in both groups COVID-19 using the Spearman rho correlation test (p < 0.000) with strengths correlation between -44.6 and 60.5. There was a significant association between platelet count and MPV value with D-Dimer in COVID-19 patients.

Keywords


COVID-19; D-Dimer; platelets; platelet index

Full Text:

PDF

References


Hong ZS, Tan YY, Chen SD, Jin HJ, Guo YR, Cao Qing D, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11. https://doi.org/10.1186/s40779-020-00240-0

Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N, et al. Coronavirus diseases (COVID-19) current status and future perspectives: A narrative review. Int. J Environ Res Public Health. 2020;17(8):E2690. https://doi.org/10.3390/ijerph17082690

Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-e25. https://doi.org/10.1016/j.jinf.2020.04.021

Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Eur Respir J. 2020;55(5):2000547. https://doi.org/10.1183/13993003.00547-2020

Joly BS, Siguret V, Veyradier A. Understanding pathophysiology of haemostasis disorders in critically ill patients with COVID-19. Intensive Care Med. 2020;46(8):1603-1606. https://doi.org/10.1007/s00134-020-06088-1

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417- 1418. https://doi.org/10.1016/S0140-6736(20)30937-5

Ullah W, Saeed R, Sarwar U, Patel R, Fischman DL. COVID-19 Complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure. JACC Case Rep. 2020;2(9):1379-1382. https://doi.org/10.1016/j.jaccas.2020.04.008

Li C, Li J, Ni H. Crosstalk Between Platelets and Microbial Pathogens. Front Immunol 2020; 11: 1962. https://doi.org/10.3389/fimmu.2020.01962

Assinger A. Platelets and infection an emerging role of platelets in viral infection. Front Immunol 2014; 5: 649. https://doi.org/10.3389/fimmu.2014.00649

Hottz ED, Azevedo-Quintanilha IG, Palhinha L, Teixeira L, Barreto EA, Pão CRR, et al. Platelet activation and platelet-monocyte aggregates formation trigger tissue factor expression in severe COVID-19 patients. Blood 2020; 136: 1330-1341. https://doi.org/10.1182/blood.2020007252

Rapkiewicz AV, Mai X, Carsons SE, Pittaluga S, Kleiner DE, Berger JS, et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. E Clinical Medicine 2020: 100434. https://doi.org/10.1016/j.eclinm.2020.100434

Yao Y, Cao J, Wang Q, Liu K, Luo Z, Yu K, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. Crit Care Emerg Med. 2020;8:49. https://doi.org/10.1186/s40560-020-00466-z

Naymagon L, Zubizarreta N, Feld J, van Gerwen M, Alsen M, Thibaud S, et al. Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19. Thromb Res. 2020; 196: 99–105. https://doi.org/10.1016/j.thromres.2020.08.032

Poudel A, Yashasa P, Anurag A, Barun B, Debika D, Tamanna B, et al. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. Nepal : A retrospective study. PLoS ONE 16(8): e0256744. https://doi.org/10.1371/journal.pone.0256744

Yardimci AC, Yildiz S, Ergen E, Balli H, Ergene E, Balli H, et al. Association between platelet indices and the severity of the disease and mortality in patients with COVID-19. Retrospective Study. European Review for Medical and Pharmacological Sciences. 2021; 25: 6731-6740. https://doi.org/10.26355/eurrev_202111_27118

Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multi-organ response. Curr Probl Cardiol. 2020:100618. https://doi.org/10.1016/j.cpcardiol.2020.100618

Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438-e440. https://doi.org/10.1016/S2352-3026(20)30145-9

Henry BM, Vikse J, Benoit S, Favaloro EJ, Lippi G. Hyperinflammation and dearangement of renin- angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020;507:167-173. https://doi.org/10.1016/j.cca.2020.04.027

Fogarty H, Townsend L, Cheallaigh CN, Bergin C, Martin-Loeches I, Browne P, et al. More on COVID-19 coagulopathy in Caucasian patients. Br J Haematol. 2020;186(6):1060-1061. https://doi.org/10.1111/bjh.16749

Geoffrey DW, Jonathan LM. The Impact of COVID-19 Disease on Platelets and Coagulation. Chicago Pathobiology 2021;88:15–27. https://doi.org/10.1159/000512007

Fan BE, Ng J, Chan SSW, Christopher D, Tso ACY, Ling LM, et al. COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis. J Thromb Thrombolysis. 2021; 51(3): 663–674. https://doi.org/10.1007/s11239-020-02318-x

Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020 Jun;127:104370. https://doi.org/10.1016/j.jcv.2020.104370

Hille L, Lenz M, Vlachos A, Grüning B, Hein L, Neumann FJ, et al. Ultrastructural, transcriptional, and functional differences between human reticulated and non-reticulated platelets. J Thromb Haemost. 2020 Aug;18(8): 2034–46. https://doi.org/10.1111/jth.14895

Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y. et al. SARS- CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol 2020; 13: 120. https://doi.org/10.1186/s13045-020-00954-7

Liu Y, Sun W, Guo Y, Chen L, Zhang L, Zhao S, et al. Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study. Platelets. 2020 May;31(4):490–6. https://doi.org/10.1080/09537104.2020.1754383

Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6):1205-1208. https://doi.org/10.1007/s00277-020-04019-0

Helms J, Tacquard C, Severac F, Leonard-Lo- rant I, Ohana M, Delabranche X, et al. CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020 Jun;46(6):1089–98. https://doi.org/10.1007/s00134-020-06062-x

Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421-1424. https://doi.org/10.1111/jth.14830

Zhou F, Ting Y, Ronghui D, Guohui F, Ying L, Zhibo L, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 March- April: 395 (10229: 1054-62. https://doi.org/10.1016/S0140-6736(20)30566-3




DOI: https://doi.org/10.18196/mmjkk.v23i1.16121

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

      

Editorial Office:
Journal Room, G1 (Biomedic) Building, Ground Floor, Faculty of Medicine and Health Science Universitas Muhammadiyah Yogyakarta, 
Jalan Lingkar Selatan (Brawijaya), Tamantirto, Kasihan, Bantul, Daerah Istimewa Yogyakarta, Indonesia
Phone: +62 274 387 656 (ext: 231)
WA : +62 811-2650-303
Website: http://journal.umy.ac.id/index.php/mm 
E-mail: mmjkk@umy.university

Creative Commons License
Mutiara Medika: Jurnal Kedokteran dan Kesehatan is licensed under a Creative Commons Attribution 4.0 International License. View My Stats